NCT02817750 - Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 5, 2017

Primary Completion Date

February 22, 2018

Study Completion Date

February 22, 2018

Conditions

Healthy

Interventions

DRUG

zolpidem hemitartarate tablet 3.5 mg (fasting + post-prandial)

zolpidem hemitartarate orodispersible tablet 3.5 mg in fasting and zolpidem hemitartarate orodispersible tablet 3.5 mg postprandial

DRUG

zolpidem hemitartarate tablet 3.5 mg (post-prandial + fasting)

zolpidem hemitartarate orodispersible tablet 3.5 mg postprandial and zolpidem hemitartarate orodispersible tablet 3.5 mg in fasting

Trial Locations (1)

UNIFAG - Unidade Integrada de Farmacologia e Gastroenterologia, Bragança Paulista